Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription 24.06.2024 3 BMJ 1 Clin Infect Dis 3 J Infect 1 J Infect Dis 1 JAMA 1 Lancet 1 N Engl J Med 2 Nat Immunol 2 Nat Med 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Science 21 Vaccine 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. VISWANATH K, Lee EJ, Dryer E
   Communication inequalities and incomplete data hinder understanding of how social media affect vaccine uptake.
   BMJ. 2024;385:e076478.
   PubMed        
   
   
2. ENRIA L, Dwyer H, Marchant M, Beckmann N, et al
   Political dimensions of misinformation, trust, and vaccine confidence in a digital age.
   BMJ. 2024;385:e079940.
   PubMed        
   
   
3. FEINMANN J
   Vaccine shortages worsen the deadliest cholera outbreaks in years.
   BMJ. 2024;385:q1228.
   PubMed        
   
   

   
   Clin Infect Dis

4. RUSS RK, Vandehei HM, Golovkina MI, Mogallapalli H, et al
   Hepatitis B-CpG vaccine series for healthcare workers who are hepatitis B vaccine nonresponders.
   Clin Infect Dis. 2024 Jun 17:ciae320. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Infect

5. ZHAI K, Dong J, Zeng J, Cheng P, et al
   Global Antigenic Landscape and Vaccine Recommendation Strategy for Low Pathogenic Avian Influenza A(H9N2) Viruses.
   J Infect. 2024 Jun 18:106199. doi: 10.1016/j.jinf.2024.106199.
   PubMed         Abstract available
   
   
6. AUDRAN R, Karoui O, Donnet L, Soumas V, et al
   Randomized, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.
   J Infect. 2024 Jun 17:106205. doi: 10.1016/j.jinf.2024.106205.
   PubMed         Abstract available
   
   
7. PANG CWK, Vale R, Lao KS, Khan AT, et al
   Increased Incidence of Invasive Pneumococcal Disease in Hong Kong in 2023.
   J Infect. 2024 May 11:106178. doi: 10.1016/j.jinf.2024.106178.
   PubMed         Abstract available
   
   

   
   J Infect Dis

8. GOSWAMI J, Baqui AH, Doreski PA, Perez Marc G, et al
   Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.
   J Infect Dis. 2024 Jun 18:jiae316. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   JAMA

9. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
   Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
   JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
   PubMed        
   
   

   
   Lancet

10. SAMARASEKERA U
    African vaccine manufacturing scheme to boost production.
    Lancet. 2024;403:2579-2580.
    PubMed        
    
    

    
    N Engl J Med

11. 
    Are We Prepared for Bird Flu?: ITT Episode 32.
    N Engl J Med. 2024;390:e59.
    PubMed        
    
    

    
    Nat Immunol

12. SCHIFFNER T, Phung I, Ray R, Irimia A, et al
    Author Correction: Vaccination induces broadly neutralizing antibody precursors to HIV gp41.
    Nat Immunol. 2024 Jun 14. doi: 10.1038/s41590-024-01891.
    PubMed        
    
    
13. VANDERHEIDEN A, Hill JD, Jiang X, Deppen B, et al
    Vaccination reduces central nervous system IL-1beta and memory deficits after COVID-19 in mice.
    Nat Immunol. 2024 Jun 20. doi: 10.1038/s41590-024-01868.
    PubMed         Abstract available
    
    

    
    Nat Med

14. LAZARUS JV, White TM, Wyka K, Ratzan SC, et al
    Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023.
    Nat Med. 2024;30:1559-1563.
    PubMed         Abstract available
    
    
15. CLIFF M, Welaga P, Mohammed N, Ansah P, et al
    Strategies for controlling pneumococcal disease and outbreaks during humanitarian emergencies.
    Nat Med. 2024;30:1515-1516.
    PubMed        
    
    

    
    PLoS One

16. CHERVO TC, Elkin EP, Nugent JR, Valice E, et al
    Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.
    PLoS One. 2024;19:e0303303.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

17. TORTORICE D, Rappuoli R, Bloom DE
    The economic case for scaling up health research and development: Lessons from the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2024;121:e2321978121.
    PubMed         Abstract available
    
    

    
    Science

18. ROBERTS L
    Wild poliovirus makes comeback in Afghanistan and Pakistan.
    Science. 2024;384:1284.
    PubMed         Abstract available
    
    

    
    Vaccine

19. ZHANG X, Monnat SM
    Watchful, skeptics, and system distrusters: Characteristics associated with different types of COVID-19 vaccine hesitancy among U.S. working-age adults.
    Vaccine. 2024 Jun 19:S0264-410X(24)00721-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
20. CARLSON CJ, Garnier R, Tiu A, Luby SP, et al
    Strategic vaccine stockpiles for regional epidemics of emerging viruses: A geospatial modeling framework.
    Vaccine. 2024 Jun 19:S0264-410X(24)00690-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
21. CARLOS GUILLERMO B, Tomas Alberto O, Julio I
    First vaccine confidence and access index in Argentina: Comparison of results from 2019 to 2022.
    Vaccine. 2024 Jun 19:S0264-410X(24)00711-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
22. CARDOSO N, Eschbaumer M, Capozzo AV
    An IgG1 single-dilution avidity ELISA predicts cross-protection against heterologous foot-and-mouth disease virus challenge after vaccination.
    Vaccine. 2024 Jun 13:S0264-410X(24)00707-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
23. HASSO-AGOPSOWICZ M, Sparrow E, Cameron AM, Sati H, et al
    The role of vaccines in reducing antimicrobial resistance: A review of potential impact of vaccines on AMR and insights across 16 vaccines and pathogens.
    Vaccine. 2024 Jun 13:S0264-410X(24)00676-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
24. DAVEY SA, Hampson C, Christodoulaki ME, Gaffiero D, et al
    Investigating the predictors of COVID-19 vaccine decision-making among parents of children aged 5-11 in the UK.
    Vaccine. 2024 Jun 13:S0264-410X(24)00646-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
25. WHITE MC, Osazuwa-Peters OL, Abouelella DK, Barnes JM, et al
    Trends and factors associated with receipt of human papillomavirus (HPV) vaccine in private, public, and alternative settings in the United States.
    Vaccine. 2024 Jun 13:S0264-410X(24)00663-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
26. SONG T, Cao F, Huang X, Wu S, et al
    Augmenting vaccine efficacy: Tailored immune strategy with alum-stabilized Pickering emulsion.
    Vaccine. 2024 Jun 13:S0264-410X(24)00649-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
27. TING DK, Rosychuk RJ, Hau JP, Righolt CH, et al
    Leveraging a clinical emergency department dataset to estimate two-dose COVID-19 vaccine effectiveness and duration of protection in Canada.
    Vaccine. 2024 Jun 14:S0264-410X(24)00699-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
28. REY-ARES L, Ta A, Freigofaite D, Warren S, et al
    Cost-effectiveness analysis of the pediatric 20-valent pneumococcal conjugate vaccine compared with lower-valent alternatives in Argentina.
    Vaccine. 2024 Jun 14:S0264-410X(24)00670-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
29. JIANG X, Wang J, Li C, Yeoh EK, et al
    Relationship between parental acceptance of the COVID-19 vaccine and attitudes towards measles vaccination for children: A cross-sectional study.
    Vaccine. 2024 Jun 15:S0264-410X(24)00708-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
30. GUL C, Gul A, Karakavuk T, Erkunt Alak S, et al
    A novel DNA vaccine encoding the SRS13 protein administered by electroporation confers protection against chronic toxoplasmosis.
    Vaccine. 2024 Jun 15:S0264-410X(24)00706-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
31. WALTENBURG MA, Kainulainen MH, Whitesell A, Nyakarahuka L, et al
    Knowledge, attitudes, and practices and long-term immune response after rVSVDeltaG-ZEBOV-GP Ebola vaccination in healthcare workers in high-risk districts in Uganda.
    Vaccine. 2024 Jun 15:S0264-410X(24)00658-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
32. DESLAURIERS F, Hoq M, Kaufman J, Enticott J, et al
    Comparison of parent-reported motivators of non-vaccination for children 5-11 years old in Australia and Canada: Results of the iCARE study.
    Vaccine. 2024 Jun 15:S0264-410X(24)00698-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
33. FERM J, Jaworski DC, Stoll I, Kleinhenz MD, et al
    Genetically modified live vaccine offers protective immunity against wild-type Anaplasma marginale tick-transmission challenge.
    Vaccine. 2024 Jun 15:S0264-410X(24)00710-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
34. YAZDAN PANAH M, Vaheb S, Mokary Y, Afshari-Safavi A, et al
    Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders.
    Vaccine. 2024 Jun 16:S0264-410X(24)00702-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
35. LAEMMLE-RUFF I, Morgan HJ, Harris A, Abruzzo V, et al
    Guillain-Barre syndrome temporally associated with COVID-19 vaccines - Progress over time.
    Vaccine. 2024 Jun 17:S0264-410X(24)00714-X. doi: 10.1016/j.vaccine.2024.
    PubMed        
    
    
36. CHENG TM, Chen YS, Wei KC, Chang YC, et al
    Assessment of the herpes zoster risk among renal transplant recipients administered the influenza vaccine.
    Vaccine. 2024 Jun 18:S0264-410X(24)00716-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
37. HOPKINS KL, Lihemo G, Underwood T, Sommers T, et al
    The second annual Vaccination Acceptance Research Network Conference (VARN2023): Shifting the immunization narrative to center equity and community expertise.
    Vaccine. 2024 Jun 18:S0264-410X(24)00655-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
38. CHICHILI GR, Smulders R, Santos V, Cywin B, et al
    Corrigendum to "Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years" [Vaccine 40 (2002) 4190-4198].
    Vaccine. 2024 Jun 18:S0264-410X(24)00650-9. doi: 10.1016/j.vaccine.2024.
    PubMed        
    
    
39. AHMED T, Tauheed I, Hoque S, Sarower Bhuyan G, et al
    A phase 3 non-inferiority trial of locally manufactured Meningococcal ACWY vaccine 'Ingovax ACWY' among Bangladeshi adults.
    Vaccine. 2024 Jun 18:S0264-410X(24)00704-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

    
    Virus Res

40. SPEDICATO M, Ronchi GF, Profeta F, Traini S, et al
    Efficacy of an inactivated EHDV-8 vaccine in preventing viraemia and clinical signs in experimentally infected cattle.
    Virus Res. 2024 Jun 17:199416. doi: 10.1016/j.virusres.2024.199416.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.